180 related articles for article (PubMed ID: 15633577)
21. Prevalence and trends of human immunodeficiency virus, hepatitis B virus, and hepatitis C virus among blood donors in Iran, 2004 through 2007.
Kafi-abad SA; Rezvan H; Abolghasemi H; Talebian A
Transfusion; 2009 Oct; 49(10):2214-20. PubMed ID: 19527477
[TBL] [Abstract][Full Text] [Related]
22. Prevalence of transfusion transmitted infections in blood donors: an Indian experience.
Chandra T; Kumar A; Gupta A
Trop Doct; 2009 Jul; 39(3):152-4. PubMed ID: 19535750
[TBL] [Abstract][Full Text] [Related]
23. Prevalence of selected viral infections among temporarily deferred donors who returned to donate blood: American Red Cross blood donor study.
Zou S; Musavi F; Notari EP; Fujii KE; Dodd RY;
Transfusion; 2005 Oct; 45(10):1593-600. PubMed ID: 16181210
[TBL] [Abstract][Full Text] [Related]
24. Seroprevalence of hepatitis B and C virus infections among Lao blood donors.
Jutavijittum P; Yousukh A; Samountry B; Samountry K; Ounavong A; Thammavong T; Keokhamphue J; Toriyama K
Southeast Asian J Trop Med Public Health; 2007 Jul; 38(4):674-9. PubMed ID: 17883005
[TBL] [Abstract][Full Text] [Related]
25. High prevalence of hepatitis B, C and delta virus infections among blood donors in Mongolia.
Tsatsralt-Od B; Takahashi M; Nishizawa T; Inoue J; Ulaankhuu D; Okamoto H
Arch Virol; 2005 Dec; 150(12):2513-28. PubMed ID: 16012782
[TBL] [Abstract][Full Text] [Related]
26. Response rate of Malaysian blood donors with reactive screening test to transfusion medicine unit calls.
Roshan TM; Rosline H; Ahmed SA; Rapiaah M; Khattak MN
Southeast Asian J Trop Med Public Health; 2009 Nov; 40(6):1315-21. PubMed ID: 20578467
[TBL] [Abstract][Full Text] [Related]
27. [Seroprevalence of hepatitis C antibodies among blood donors. Study of second generation ELISA and RIBA tests and surrogate markers].
Aymard JP; Botte C; Contal P; Janot C; Streiff F
Pathol Biol (Paris); 1993 Feb; 41(2):149-53. PubMed ID: 8327265
[TBL] [Abstract][Full Text] [Related]
28. Prevalence of Hepatitis B and C in the normal population and high risk groups in north Kerala.
Sandesh K; Varghese T; Harikumar R; Beena P; Sasidharan VP; Bindu CS; Tony J; Harish K; Sunilkumar K; Ramachandran TM
Trop Gastroenterol; 2006; 27(2):80-3. PubMed ID: 17089617
[TBL] [Abstract][Full Text] [Related]
29. Significance of the signal-to-cutoff ratios of anti-hepatitis C virus enzyme immunoassays in screening of Chinese blood donors.
Ren FR; Lv QS; Zhuang H; Li JJ; Gong XY; Gao GJ; Liu CL; Wang JX; Yao FZ; Zheng YR; Zhu FM; Tiemuer MH; Bai XH; Shan H
Transfusion; 2005 Nov; 45(11):1816-22. PubMed ID: 16271110
[TBL] [Abstract][Full Text] [Related]
30. Prevalence of hepatitis B and C among HIV positive patients in Georgia and its associated risk factors.
Badridze N; Chkhartishvili N; Abutidze A; Gatserelia L; Sharvadze L
Georgian Med News; 2008 Dec; (165):54-60. PubMed ID: 19124918
[TBL] [Abstract][Full Text] [Related]
31. [Prevalence of antibodies against human immunodeficiency virus (HIV) and other infectious disease markers in blood donors from the city of Puebla].
Marín López A
Rev Invest Clin; 1987; 39(3):219-22. PubMed ID: 3481100
[No Abstract] [Full Text] [Related]
32. Prevalence and risk factors of hepatitis C virus, hepatitis B virus, and human immunodeficiency virus in multiply transfused recipients in Mexico.
Calderón GM; González-Velázquez F; González-Bonilla CR; Novelo-Garza B; Terrazas JJ; Martínez-Rodríguez ML; Cortés-Márquez SR; Blanco-Flores JP; Rodríguez-Rodríguez A; Del Campo MA; Cortés-Gómez R; Mejía-Bocanegra MG
Transfusion; 2009 Oct; 49(10):2200-7. PubMed ID: 19538543
[TBL] [Abstract][Full Text] [Related]
33. [HIV in Mexican blood donors and estimated transfusional risk].
Arreguín V; Alvarez P; Simón JI; Valderrama JA; Macías AE
Rev Invest Clin; 2008; 60(4):278-83. PubMed ID: 18956548
[TBL] [Abstract][Full Text] [Related]
34. [Prevalence of hepatitis B and C infection and HIV infection in blood donors and patients from the internal diseases ward].
Kozik T; Bujak K
Przegl Lek; 1996; 53(3):159-61. PubMed ID: 8754372
[TBL] [Abstract][Full Text] [Related]
35. Prevalence of hepatitis B and C serological markers among first-time blood donors in Brazil: a multi-center serosurvey.
Nascimento MC; Mayaud P; Sabino EC; Torres KL; Franceschi S
J Med Virol; 2008 Jan; 80(1):53-7. PubMed ID: 18041005
[TBL] [Abstract][Full Text] [Related]
36. Epidemiology of antibody to hepatitis B core antigen screening among blood donors in Eastern Saudi Arabia. Need to replace the test by HBV DNA testing.
Panhotra BR; Al-Bahrani A; Ul-Hassan Z
Saudi Med J; 2005 Feb; 26(2):270-3. PubMed ID: 15770304
[TBL] [Abstract][Full Text] [Related]
37. [Prevalance of antibodies against hepatitis C and B viruses in patients with systemic lupus erythematosus].
Mercado U; Avendaño-Reyes M; Araiza-Casillas R; Díaz-Molina R
Rev Gastroenterol Mex; 2005; 70(4):399-401. PubMed ID: 17058978
[TBL] [Abstract][Full Text] [Related]
38. Impact of nucleic acid testing for hepatitis B virus, hepatitis C virus, and human immunodeficiency virus on the safety of blood supply in Italy: a 6-year survey.
Velati C; Romanò L; Fomiatti L; Baruffi L; Zanetti AR;
Transfusion; 2008 Oct; 48(10):2205-13. PubMed ID: 18631163
[TBL] [Abstract][Full Text] [Related]
39. Predonation screening of blood donors with rapid tests: implementation and efficacy of a novel approach to blood safety in resource-poor settings.
Owusu-Ofori S; Temple J; Sarkodie F; Anokwa M; Candotti D; Allain JP
Transfusion; 2005 Feb; 45(2):133-40. PubMed ID: 15660820
[TBL] [Abstract][Full Text] [Related]
40. [Prevalence of hepatitis G virus among Tunisian blood donors].
Mastouri M; Safer IL; Pozzetto B; Bourlet T; Khedher M
East Mediterr Health J; 2005; 11(5-6):1053-60. PubMed ID: 16761677
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
